NF10 Project: An International, Prospective, Observational Study Of Patients With Indolent Non-Follicular Lymphoma. Analysis Of First 215 Patients

被引：1
|
作者：
Arcaini, Luca
Luminari, Stefano
Cesaretti, Marina
Gaidano, Gianluca
Rattotti, Sara
Merli, Michele
Cabras, Maria Giuseppina
Spina, Michele
Baldini, Luca
Tedeschi, Alessandra
Orsucci, Lorella
da Silva, Maria Comes
Marcheselli, Luigi
Marcia, Torresan Delamein
Federico, Massimo
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1782.1782
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1782
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Feasibility and Toxicity of Concomitant Radio/Immunotherapy with MabThera (Rituximab®) for Patients with Non-Hodkin's Lymphoma. Results of a Prospective Phase I/II Study
    Haidenberger, Alfred
    Fromm-Haidenberger, Sabine
    de Vries, Alexander
    Popper, Bela-Andre
    Steurer, Michael
    Skvortsova, Ira
    Kantner, Johanna
    Gunsilius, Eberhard
    Lukas, Peter
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (05) : 300 - 305
  • [42] Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study
    Pott, Christiane
    Jurinovic, Vindi
    Trotman, Judith
    Kehden, Britta
    Unterhalt, Michael
    Herold, Michael
    van der Jagt, Richard
    Janssens, Ann
    Kneba, Michael
    Mayer, Jiri
    Young, Moya
    Schmidt, Christian
    Knapp, Andrea
    Nielsen, Tina
    Brown, Helen
    Spielewoy, Nathalie
    Harbron, Chris
    Bottos, Alessia
    Mundt, Kirsten
    Marcus, Robert
    Hiddemann, Wolfgang
    Hoster, Eva
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (05) : 550 - 561
  • [43] Primary Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel in Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
    Jacobson, Caron
    Chavez, Julio C.
    Sehgal, Alison R.
    William, Basem M.
    Munoz, Javier
    Salles, Gilles
    Munshi, Pashna N.
    Casulo, Carla
    Maloney, David
    de Vos, Sven
    Reshef, Ran
    Leslie, Lori A.
    Yakoub-Agha, Ibrahim
    Oluwole, Olalekan O.
    Fung, Henry C. H.
    Rosenblatt, Joseph D.
    Rossi, John M.
    Goyal, Lovely
    Plaks, Vicki
    Yang, Yin
    Lee, Jennifer
    Godfrey, Wayne
    Vezan, Remus
    Avanzi, Mauro P.
    Neelapu, Sattva S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (01) : 5 - 6
  • [44] Primary analysis of ZUMA-5: A phase 2 study of axicabtagene ciloleucel in patients with relapsed/refractory indolent non-hodgkin lymphoma
    Jacobson, Caron A.
    Chavez, Julio C.
    Sehgal, Alison R.
    William, Basem M.
    Munoz, Javier
    Salles, Gilles
    Munshi, Pashna N.
    Casulo, Carla
    Maloney, David G.
    De Vos, Sven
    Reshef, Ran
    Leslie, Lori A.
    Yakoub-Agha, Ibrahim
    Oluwole, Olalekan O.
    Fung, Henry Chi Hang
    Rosenblatt, Joseph
    Rossi, John M.
    Goyal, Lovely
    Plaks, Vicki
    Yang, Yin
    Lee, Jennifer
    Godfrey, Wayne
    Vezan, Remus
    Avanzi, Mauro P.
    Neelapu, Sattva S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 34 - 36
  • [45] Primary Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel in Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
    Jacobson, Caron
    Chavez, Julio C.
    Sehgal, Alison R.
    William, Basem M.
    Munoz, Javier
    Salles, Gilles
    Munshi, Pashna N.
    Casulo, Carla
    Maloney, David
    de Vos, Sven
    Reshef, Ran
    Leslie, Lori A.
    Yakoub-Agha, Ibrahim
    Oluwole, Olalekan O.
    Fung, Henry C. H.
    Rosenblatt, Joseph D.
    Rossi, John M.
    Goyal, Lovely
    Plaks, Vicki
    Yang, Yin
    Lee, Jennifer
    Godfrey, Wayne
    Vezan, Remus
    Avanzi, Mauro P.
    Neelapu, Sattva S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (03) : 8 - 9
  • [46] Prospective validation of the FLIPI: Baseline distribution and correlates in newly diagnosed follicular lymphoma (FL) patients from the US: First report of The National LymphoCare Study
    Link, BK
    Cerhan, JR
    Dillon, H
    Farber, CM
    Feliciano, S
    Friedberg, JW
    Hainsworth, J
    Steis, R
    Vose, JM
    Zelenetz, AD
    BLOOD, 2005, 106 (11) : 293A - 293A
  • [47] Updated Results of the Phase III Study of First-Line Bendamustine/Rituximab Versus CHOP plus Rituximab in Patients with Indolent Non-Hodgkin Lymphoma
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (02): : 128 - 129
  • [48] The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective International T-Cell Project
    Bellei, Monica
    Federico, Massimo
    HAEMATOLOGICA, 2019, 104 (04)
  • [49] An international multicenter observational non-interventional prospective study of the efficacy of azilsartan medoxomil in overweight or obese patients with arterial hypertension (CONSTANT)
    Chazova, Irina E.
    Zhernakova, Yulia V.
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (02) : 185 - 193
  • [50] The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project
    Bellei, Monica
    Foss, Francine M.
    Shustov, Andrei R.
    Horwitz, Steven M.
    Marcheselli, Luigi
    Kim, Won Seog
    Cabrera, Maria E.
    Dlouhy, Ivan
    Nagler, Arnon
    Advani, Ranjana H.
    Pesce, Emanuela A.
    Ko, Young-Hyeh
    Martinez, Virginia
    Montoto, Silvia
    Chiattone, Carlos
    Moskowitz, Alison
    Spina, Michele
    Biasoli, Irene
    Manni, Martina
    Federico, Massimo
    HAEMATOLOGICA, 2018, 103 (07) : 1191 - 1197
12345